IAA
PMVP icon

Independent Advisor Alliance’s PMV Pharmaceuticals PMVP Stock Holding History

Independent Advisor Alliance’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5K Hold
12,500
– – ﹤0.01% 1588
2025
Q4 		$15.6K Hold
12,500
– – ﹤0.01% 994
2025
Q3 		$17.5K Hold
12,500
– – ﹤0.01% 938
2025
Q2 		$13.3K Hold
12,500
– – ﹤0.01% 886
2025
Q1 		$13.6K Sell
12,500
-14
-0.1% -$19 ﹤0.01% 809
2024
Q4 		$18.9K Sell
12,514
-759
-6% -$1.2K ﹤0.01% 1344
2024
Q3 		$19.8K Buy
13,273
+773
+6% +$1.19K ﹤0.01% 700
2024
Q2 		$20.3K Hold
12,500
– – ﹤0.01% 694
2024
Q1 		$21.3K Hold
12,500
– – ﹤0.01% 695
2023
Q4 		$38.8K Buy
+12,500
New +$33.1K ﹤0.01% 665

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Independent Advisor Alliance's PMVP Position: Q1 2026 in Review

Independent Advisor Alliance held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 12,500 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

Independent Advisor Alliance first reported a position in PMVP in Q4 2023 and has held it in 10 quarters since. The position peaked at $38.8K in Q4 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Independent Advisor Alliance held 12,500 shares of PMV Pharmaceuticals worth $15.5K as of Q1 2026.
  • Independent Advisor Alliance left its PMV Pharmaceuticals share count unchanged in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Independent Advisor Alliance's portfolio in Q1 2026, its #1588 holding.
  • Independent Advisor Alliance first reported a position in PMV Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Independent Advisor Alliance's PMV Pharmaceuticals position peaked at $38.8K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.